Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Schmidt

Showing results (341-350 of 350) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 350 results.
Thrombosis Journal|January 2, 2019
Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III studyAnthonie W A Lensing, Christoph Male, Guy Young, et al.
Aging|March 10, 2016
MicroRNA-15b regulates mitochondrial ROS production and the senescence-associated secretory phenotype through sirtuin 4/SIRT4Alexander Lang, Susanne Grether-Beck, Madhurendra Singh, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 26, 2019
Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophyDaniela J Conrado, Jane Larkindale, Alexander Berg, et al.
Brain : a Journal of Neurology|December 1, 2021
Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunityMarie Liebmann, Lisanne Korn, Claudia Janoschka, et al.
Clinical and Translational Science|April 30, 2022
A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalenceScott A Mosley, Sarah Kim, Nihal El Rouby, et al.
ACS Biomaterials Science & Engineering|December 15, 2020
Comparative Animal Mucomics: Inspiration for Functional Materials from Ubiquitous and Understudied BiopolymersAntonio R Cerullo, Tsoi Ying Lai, Bassem Allam, et al.
Journal of Thrombosis and Haemostasis : JTH|April 5, 2020
Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluationGuy Young, Anthonie W A Lensing, Paul Monagle, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 17, 2020
Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype-Derived Activity ScoresCameron D Thomas, Scott A Mosley, Sarah Kim, et al.
Der Nervenarzt|July 23, 2021
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Therapeutic Advances in Neurological Disorders|August 23, 2021
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Pageof 35

Showing results (341-350 of 350) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 350 results.
Thrombosis Journal|January 2, 2019
Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III studyAnthonie W A Lensing, Christoph Male, Guy Young, et al.
Aging|March 10, 2016
MicroRNA-15b regulates mitochondrial ROS production and the senescence-associated secretory phenotype through sirtuin 4/SIRT4Alexander Lang, Susanne Grether-Beck, Madhurendra Singh, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 26, 2019
Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophyDaniela J Conrado, Jane Larkindale, Alexander Berg, et al.
Brain : a Journal of Neurology|December 1, 2021
Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunityMarie Liebmann, Lisanne Korn, Claudia Janoschka, et al.
Clinical and Translational Science|April 30, 2022
A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalenceScott A Mosley, Sarah Kim, Nihal El Rouby, et al.
ACS Biomaterials Science & Engineering|December 15, 2020
Comparative Animal Mucomics: Inspiration for Functional Materials from Ubiquitous and Understudied BiopolymersAntonio R Cerullo, Tsoi Ying Lai, Bassem Allam, et al.
Journal of Thrombosis and Haemostasis : JTH|April 5, 2020
Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluationGuy Young, Anthonie W A Lensing, Paul Monagle, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 17, 2020
Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype-Derived Activity ScoresCameron D Thomas, Scott A Mosley, Sarah Kim, et al.
Der Nervenarzt|July 23, 2021
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Therapeutic Advances in Neurological Disorders|August 23, 2021
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Pageof 35